Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292 (Q71808044)
Jump to navigation
Jump to search
scientific article published on 01 December 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292 |
scientific article published on 01 December 1996 |
Statements
Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292 (English)
J A Sparano
S Lipsitz
S Wadler
R Hansen
P W Bushunow
J Kirkwood
P J Flynn
1 December 1996